2Nigrovic V, Amann A. Simulation of interaction between two nondepolarizing muscle relaxants:generation of an additive or a supraadditive neuromuscular block. J Pharmacokinetics Pharmacodynamics,2004,31 : 157-179.
3Paul M, Kindler CH, Fokt RM, et al. Isobolographie analysis of non- -depolarizing musele relaxant interactions at their receptor site. Eu J Pharmacol,2002,438:35-43.
4Paton WDM, Wand DR. The margin of safety of neuromuscular transmission. J Physio,1967,191:59-90.
5Wand DR,Wand BE. The relation between tetanie fade arid receptor occlusion in the presence of competitive neuromuscular Block. Anesthesiology, 1971,35:456-461.
6Kim KS, Chun YS, Chon SU, et al. Neuromuscular interaction between cisatracurium and mivacurium, atracurium, vecuronium or rocuronium administered in combination. Anaesthesia,1998,53: 872-878.
7Zeidan A, Nahle N, Maaliki H, et al. cisatracurium or rocuronium versus rocuronium-cisatracurium combination. Middle East J Anesthesiol,2006,18:879-886.
8Naguib M, Samarkandi AH, Ammar A, et al. Comparative clinical pharmacology of rocuronium, cisatracurium, and their combination. Anesthesiology, 1999,91:587-588.
9Fisher DM, Rosen JI. A pharmacokinetic explanation for increasing recovery time following larger or repeated doses of nondepolarizing muscle relaxants. Anesthesiology,1986,65:286-291.
